Form 8-K - Current report:
SEC Accession No. 0000950168-03-000116
Filing Date
2003-01-15
Accepted
2003-01-15 12:47:22
Documents
3
Period of Report
2003-01-13
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 11428
3 PRESS RELEASE-JANUARY 14 dex991.htm EX-99.1 3969
4 PRESS RELEASE-JANUARY 15 dex992.htm EX-99.2 6164
  Complete submission text file 0000950168-03-000116.txt   23506
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-27410 | Film No.: 03514597
SIC: 2834 Pharmaceutical Preparations